Cargando…

Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients

AIMS: Gleason pattern 4 (GP4) percentage, invasive cribriform and/or intraductal carcinoma (IC/IDC) and the presence of tertiary Gleason pattern 5 (TP5) in radical prostatectomy (RP) specimens all aid in the risk stratification of Grade Group (GG) 2 prostate cancer patients. However, it is unclear t...

Descripción completa

Detalles Bibliográficos
Autores principales: Seyrek, Neslisah, Hollemans, Eva, Osanto, Susanne, Pelger, Rob C M, van der Poel, Henk G, Bekers, Elise, Bangma, Chris H, Rietbergen, John, Roobol, Monique J, Schoots, Ivo G, van Leenders, Geert J L H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299672/
https://www.ncbi.nlm.nih.gov/pubmed/34706119
http://dx.doi.org/10.1111/his.14590
_version_ 1784751028701233152
author Seyrek, Neslisah
Hollemans, Eva
Osanto, Susanne
Pelger, Rob C M
van der Poel, Henk G
Bekers, Elise
Bangma, Chris H
Rietbergen, John
Roobol, Monique J
Schoots, Ivo G
van Leenders, Geert J L H
author_facet Seyrek, Neslisah
Hollemans, Eva
Osanto, Susanne
Pelger, Rob C M
van der Poel, Henk G
Bekers, Elise
Bangma, Chris H
Rietbergen, John
Roobol, Monique J
Schoots, Ivo G
van Leenders, Geert J L H
author_sort Seyrek, Neslisah
collection PubMed
description AIMS: Gleason pattern 4 (GP4) percentage, invasive cribriform and/or intraductal carcinoma (IC/IDC) and the presence of tertiary Gleason pattern 5 (TP5) in radical prostatectomy (RP) specimens all aid in the risk stratification of Grade Group (GG) 2 prostate cancer patients. However, it is unclear to what extent these pathological features are mutually related and what are their individual values if they are investigated simultaneously. The aims of this study were: (i) to determine the mutual relationships of the GP4 percentage, IC/IDC and TP5 in GG2 RP specimens; and (ii) to assess their prognostic value for biochemical recurrence‐free survival (BCRFS). METHODS AND RESULTS: Of 1064 RP specimens, 472 (44.4%) showed GG2 prostate cancer. Patients with ≥25% GP4 more frequently had IC/IDC (67.0% versus 43.9%; P < 0.001) and TP5 (20.6% versus 5.8%; P < 0.001) than those with <25% GP4. In unadjusted analysis, an increased GP4 percentage [hazard ratio (HR) 1.3; 95% confidence interval (CI) 1.0–1.6; P = 0.04] and IC/IDC (log rank P < 0.001) were associated with shorter BCRFS, whereas TP5 (P = 0.12) and a dichotomised (<25%, ≥25%) GP4 percentage (P = 0.10) were not. In multivariable analysis, IC/IDC was an independent prognostic factor (HR 1.9; 95% CI 1.2–2.9; P = 0.005) for BCRFS, whereas a continuous or dichotomised GP4 percentage and TP5 were not independent prognostic factors. CONCLUSION: In conclusion, a higher GP4 percentage in RP specimens was associated with more frequent IC/IDC and TP5. IC/IDC was an independent predictor for BCRFS, whereas the GP4 percentage and TP5 were not. These findings underscore the importance of routinely including the presence of IC/IDC in RP pathology reports.
format Online
Article
Text
id pubmed-9299672
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92996722022-07-21 Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients Seyrek, Neslisah Hollemans, Eva Osanto, Susanne Pelger, Rob C M van der Poel, Henk G Bekers, Elise Bangma, Chris H Rietbergen, John Roobol, Monique J Schoots, Ivo G van Leenders, Geert J L H Histopathology Original Articles AIMS: Gleason pattern 4 (GP4) percentage, invasive cribriform and/or intraductal carcinoma (IC/IDC) and the presence of tertiary Gleason pattern 5 (TP5) in radical prostatectomy (RP) specimens all aid in the risk stratification of Grade Group (GG) 2 prostate cancer patients. However, it is unclear to what extent these pathological features are mutually related and what are their individual values if they are investigated simultaneously. The aims of this study were: (i) to determine the mutual relationships of the GP4 percentage, IC/IDC and TP5 in GG2 RP specimens; and (ii) to assess their prognostic value for biochemical recurrence‐free survival (BCRFS). METHODS AND RESULTS: Of 1064 RP specimens, 472 (44.4%) showed GG2 prostate cancer. Patients with ≥25% GP4 more frequently had IC/IDC (67.0% versus 43.9%; P < 0.001) and TP5 (20.6% versus 5.8%; P < 0.001) than those with <25% GP4. In unadjusted analysis, an increased GP4 percentage [hazard ratio (HR) 1.3; 95% confidence interval (CI) 1.0–1.6; P = 0.04] and IC/IDC (log rank P < 0.001) were associated with shorter BCRFS, whereas TP5 (P = 0.12) and a dichotomised (<25%, ≥25%) GP4 percentage (P = 0.10) were not. In multivariable analysis, IC/IDC was an independent prognostic factor (HR 1.9; 95% CI 1.2–2.9; P = 0.005) for BCRFS, whereas a continuous or dichotomised GP4 percentage and TP5 were not independent prognostic factors. CONCLUSION: In conclusion, a higher GP4 percentage in RP specimens was associated with more frequent IC/IDC and TP5. IC/IDC was an independent predictor for BCRFS, whereas the GP4 percentage and TP5 were not. These findings underscore the importance of routinely including the presence of IC/IDC in RP pathology reports. John Wiley and Sons Inc. 2021-12-14 2022-02 /pmc/articles/PMC9299672/ /pubmed/34706119 http://dx.doi.org/10.1111/his.14590 Text en © 2021 The Authors. Histopathology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Seyrek, Neslisah
Hollemans, Eva
Osanto, Susanne
Pelger, Rob C M
van der Poel, Henk G
Bekers, Elise
Bangma, Chris H
Rietbergen, John
Roobol, Monique J
Schoots, Ivo G
van Leenders, Geert J L H
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
title Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
title_full Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
title_fullStr Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
title_full_unstemmed Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
title_short Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients
title_sort cribriform architecture outperforms gleason pattern 4 percentage and tertiary gleason pattern 5 in predicting the outcome of grade group 2 prostate cancer patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299672/
https://www.ncbi.nlm.nih.gov/pubmed/34706119
http://dx.doi.org/10.1111/his.14590
work_keys_str_mv AT seyrekneslisah cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT hollemanseva cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT osantosusanne cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT pelgerrobcm cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT vanderpoelhenkg cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT bekerselise cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT bangmachrish cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT rietbergenjohn cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT roobolmoniquej cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT schootsivog cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients
AT vanleendersgeertjlh cribriformarchitectureoutperformsgleasonpattern4percentageandtertiarygleasonpattern5inpredictingtheoutcomeofgradegroup2prostatecancerpatients